Status:
COMPLETED
Occult HCV Infection After DAAD Treatment in Haemodialysis Patients
Lead Sponsor:
Alexandria University
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research aims to evaluate the prevalence and predictors of Occult HCV among hemodialysis (HD) patients who achieved 24 weeks sustained virological response (SVR) after treatment with direct-actin...
Detailed Description
In maintenance hemodialysis (MHD) patients, hepatitis C virus (HCV) infection is common and may be associated with poor clinical outcomes. A lot of treatment options for HCV have rapidly evolved over ...
Eligibility Criteria
Inclusion
- Patients on regular hemodialysis treatment for more than 6 months.
- Achieved sustained virological response 24 weeks after the end of treatment with directly acting antiviral drugs (DAADs).
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04719338
Start Date
March 1 2021
End Date
October 1 2021
Last Update
April 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Alexandria University
Alexandria, Egypt